feed,title,long_url,short_url
BioRxiv,"CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approach",https://biorxiv.org/cgi/content/short/2021.07.26.453805v1?rss=1,https://j.mp/3f39mIy
